Board of Directors

Board members

• 

  Director

  Al Benson III, MD, FACP

  Professor of Medicine, Associate Director for Clinical Investigations, Robert H. Lurie Comprehensive Cancer Center of Northwestern University

• 

  Vice Chair

  Chase Bice

  Partner, PricewaterhouseCoopers US Business Advisory LLP

• 

  Director; Audit, Risk Oversight, and Compliance Committee Chair

  Jennifer S. Brown, JD

  Chief Administrative Officer and General Counsel, Graphite Health

• 

  Founder and Chair Emerita

  Nancy Davenport-Ennis

• 

  Transition Co-chair (through June 30, 2026)

  James Dunlop, JD, MD

  Dermatologist and Dermatologic Surgeon, InterMed

• 

  Treasurer | Finance Committee Chair

  Norm Hubbard, MBA

  Chief Business Officer, Office of Health Sciences, Michigan State University, Former Executive Vice President, Seattle Cancer Care Alliance

• 

  Director

  Laurie G. Hughes, MBA

  Consultant & Advisor

• 

  Director | Clinical Review Committee Chair

  Nicholas Larochelle, MD

  Board-Certified Emergency Medicine Physician and Associate Chief Clinical Officer, Concord Hospital Health System

• 

  Transition Co-chair (through June 30, 2026)

  Otis Maynard, Esq.

  Senior Associate General Counsel, United Healthcare

• 

  Director

  Anna McKean

  CEO, Master Center for Addiction Medicine

• 

  Director

  John L. Murphy

  Retired Partner & Head of Research, Saguenay Strathmore Capital

• 

  Director | Governance Committee Chair

  Winfred Parnell, MD

  University of Texas Southwestern Medical Center (retired)

• 

  Director

  Jon Sellman

  Chief Brand Officer, M&T Bank

• 

  Director

  Sarah Thomason, PharmD, BCPP, BCACP, FAAPP

  Chair and Professor of Pharmacy Practice, Gatton College of Pharmacy at East Tennessee State University and Clinical Pharmacist, ETSU Health Internal Medicine and ETSU Center of Excellence for HIV/AIDS Care

• 

  Director

  Reginald Tucker-Seeley, MA, ScM, ScD

  Principal/Owner, Health Equity Strategies and Solutions; Former Vice President of Health Equity, ZERO – The End of Prostate Cancer

• 

  Secretary

  David White

  Lead Proofreader, Debevoise Plimpton, LLP, Patient Partner, National Committee for Quality Assurance, Patient Representative, NIIH Health Initiative